Needham Maintains Buy on Alkermes, Raises Price Target to $61

Benzinga Newsdesk www.benzinga.com Positive 71.7%

Neg 0% Neu 0% Pos 71.7%

Needham analyst Ami Fadia maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $54 to $61.

Comments

No comments yet. Be the first!